Quanterix (NASDAQ: QTRX)
Quanterix Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
Quanterix Company Info
Quanterix Corp. engages in the development of ultra-sensitive digital immunoassay platform that advances precision health for life sciences research and diagnostics. Its products and services include Simoa Assay Kits, HD-X analyzer, SR-X Biomarker Detection System, SP-X Imaging and Analysis System, 2470 Arrayer, Simoa Accelerator Laboratory, Uman NF-Light, and Homebrew -Custom Assay Development. The company was founded by Nicholas J. Naclerio and David R. Walt in April 2007 and is headquartered in Billerica, MA.
News & Analysis
Why Quanterix Stock Bounced Back on Wednesday
The market might, just might, have over-reacted to the company's dispiriting second-quarter results the previous day.
Why Quanterix Shares Plunged by Nearly 55% Today
Investors gave the thumbs-down to the biotech's latest reported quarter.
Valuation
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.